最高溢价近43%!葛兰素史克(GSK.US)拟斥资90-100亿美元收购肿瘤药企Nuvalent(NUVL.US)

智通财经06-09

智通财经APP获悉，葛兰素史克(GSK.US)正就收购肿瘤治疗药企Nuvalent Inc.(NUVL.US)进行磋商，交易对价在90亿至100亿美元之间。报道称，两家公司周一晚间正密集磋商，目标是最快于本周达成协议，但交易仍存在临门一脚的变数，不排除彻底谈崩的可能。本次交易将对总部位于马萨诸塞州剑桥市的Nuvalent(当前市值近70亿美元)给出高额溢价，这也将成为葛兰素史克史上规模最大的收购案...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2642567024?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-09 11:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642567024","market":"fut","top_or_hot":-1,"title":"最高溢价近43%!葛兰素史克(GSK.US)拟斥资90-100亿美元收购肿瘤药企Nuvalent(NUVL.US)","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，葛兰素史克(GSK.US)正就收购肿瘤治疗药企Nuvalent Inc.(NUVL.US)进行磋商，交易对价在90亿至100亿美元之间。报道称，两家公司周一晚间正密集磋商，目标是最快于本周达成协议，但交易仍存在临门一脚的变数，不排除彻底谈崩的可能。本次交易将对总部位于马萨诸塞州剑桥市的Nuvalent(当前市值近70亿美元)给出高额溢价，这也将成为葛兰素史克史上规模最大的收购案...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1451825.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>最高溢价近43%!葛兰素史克(GSK.US)拟斥资90-100亿美元收购肿瘤药企Nuvalent(NUVL.US)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n最高溢价近43%!葛兰素史克(GSK.US)拟斥资90-100亿美元收购肿瘤药企Nuvalent(NUVL.US)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-09 11:18 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1451825.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，葛兰素史克(GSK.US)正就收购肿瘤治疗药企Nuvalent Inc.(NUVL.US)进行磋商，交易对价在90亿至100亿美元之间。报道称，两家公司周一晚间正密集磋商，目标是最快于本周达成协议，但交易仍存在临门一脚的变数，不排除彻底谈崩的可能。本次交易将对总部位于马萨诸塞州剑桥市的Nuvalent(当前市值近70亿美元)给出高额溢价，这也将成为葛兰素史克史上规模最大的收购案...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1451825.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GSK.UK","symbol_name":"葛兰素史克","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1451825.html","article_id":"2642567024","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642567024","pubTimestamp":1780975127,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，葛兰素史克正就收购肿瘤治疗药企Nuvalent Inc.进行磋商，交易对价在90亿至100亿美元之间。本次交易将对总部位于马萨诸塞州剑桥市的Nuvalent给出高额溢价，这也将成为葛兰素史克史上规模最大的收购案之一。在退出肿瘤领域多年后，葛兰素史克近期才重新回归这一赛道。今年1月，葛兰素史克曾同意以22亿美元收购一家专注于炎症与免疫疾病治疗药物研发的美国生物科技公司Rapt Therapeutics，并在另一笔交易中获得了一款肺动脉高压药物。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"GSK.UK":"葛兰素史克","BK4139":"生物科技","BK4532":"文艺复兴科技持仓","GSK":"葛兰素史克","GSKH":"GSK plc ADRhedged","BK4585":"ETF&股票定投概念","BK4007":"制药","BK4588":"碎股","LU1829250122.USD":"高盛欧洲核心股票组合Acc","BK4539":"次新股","NUVL":"Nuvalent, Inc."},"translate_title":"The highest premium is nearly 43%! GlaxoSmithKline (GSK.US) plans to spend $9-10 billion to acquire oncology pharmaceutical company Nuvalent (NUVL.US)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSKH":0.6,"GSK":1.5,"GSK.UK":0.6,"NUVL":1.5},"content_text":"智通财经APP获悉，葛兰素史克(GSK.US)正就收购肿瘤治疗药企Nuvalent Inc.(NUVL.US)进行磋商，交易对价在90亿至100亿美元之间。报道称，两家公司周一晚间正密集磋商，目标是最快于本周达成协议，但交易仍存在临门一脚的变数，不排除彻底谈崩的可能。本次交易将对总部位于马萨诸塞州剑桥市的Nuvalent(当前市值近70亿美元)给出高额溢价，这也将成为葛兰素史克史上规模最大的收购案之一。此次收购传闻正值葛兰素史克新任CEO卢克・米尔斯(Luke Miels)推动公司复兴之际，此前分析师曾表示，米尔斯可能会推行效率提升计划，同时通过加码并购来丰富公司的新药管线。这家英国药企并非以激进冒险著称，长期以来一直难以缓解投资者对其新药管线的担忧。在退出肿瘤领域多年后，葛兰素史克近期才重新回归这一赛道。从第一财季的增长引擎来看，公司的专科药物业务表现强劲。用于治疗子宫内膜癌的Jemperli和用于预防HIV的Apretude等专科药物预计今年将实现低两位数的增长，成为推动业绩的主要动力。今年1月，葛兰素史克曾同意以22亿美元收购一家专注于炎症与免疫疾病治疗药物研发的美国生物科技公司Rapt Therapeutics(RAPT.US)，并在另一笔交易中获得了一款肺动脉高压药物。据报道，该公司还计划为一款其寄予厚望的肿瘤重磅药物同步开展五项后期临床试验。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2642567024","isCrawlerRequest":true}